Drug Injection Devices to 2018
Greystone Research Associates is pleased to announce the publication of a new market study. Drug Injection Devices to 2018: Devices, Markets, Strategies and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants supplying the syringes and injectors that are revolutionizing the way that injectable drugs are being supplied and administered. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the device options, market factors, economics, technologies, disease segments, and commercial opportunities for injection devices. Provider organization business managers, healthcare administrators and investors will also benefit from this study. The Proliferation and Penetration of New Injection Device Technology
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.
THE INJECTION DEVICE ECOSYSTEM
DEVICE MANUFACTURERS
CAPABILITIES AND GEOGRAPHIC PRESENCE
SUPPLY CHAIN DYNAMICS
ALLIANCES AND COLLABORATIONS
DESIGN AND TECHNOLOGY
DEVICE DESIGN
SPECIALTY SERVICES
CMOS AND CSOS
FILL AND FINISH OPERATIONS
SPECIALTY SERVICES
INJECTION DEVICE SELECTION CRITERIA
STABILITY AND MATERIAL SELECTION ISSUES
SINGLE VS MULTI-DOSE DEVICES
LYOPHILIZED DRUGS/RECONSTITUTION
SYRINGE SAFETY/SHARPS PROTECTION
NEEDLE CONFIGURATION STRATEGIES
DISPOSABLE DRUG CARTRIDGES
HUMAN ENGINEERING/ERGONOMICS
BRANDING/PRIVATE LABELING
INJECTABLE DRUG DELIVERY – DEVICE SEGMENTS
AUTOINJECTORS
Autoinjector-specific Selection Factors
PART COUNTS AND DEVICE COST
SAFETY FEATURES
NEEDLE SHIELDING
NEEDLE INSERTION DEPTH
Failsafe Activation
Dose Inspection/Injection Confirmation
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Drugs and Therapeutic Segments
NEEDLE-FREE INJECTORS
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Energy Source/Injection Site Selection
PEN INJECTORS
Pen Injector Device Categories
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Branded Drug/Pen Injector Product by Therapeutic Segment
PREFILLED SYRINGES
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Prefillable Glass Syringe Manufacturers and Branded Devices
Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
Plastic Prefilled Syringes
Branded Prefillable Plastic Syringes
Drugs and Therapeutic Segments
Prefillable Safety Syringes
Prefilled Syringe-specific Selection Factors
PFS Manufacturing Factors
FILL-AND-FINISH OPERATIONS
SAFETY SYRINGES
Safety Syringe Device Categories
Prefillable Integrated Safety Syringes
Non-Prefillable Integrated Safety Syringes
Retractable Needle
Manually Retractable
Automatic Retractable
Sliding Sheath
DRUG INJECTION DEVICE MARKET SEGMENT ANALYSIS & FORECASTS
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Emergency Medicine
Hematopoietics
Hormone Replacement
Metabolic Diseases
Neurology
Reproductive Health
Vaccines
INJECTABLE DRUG THERAPEUTICS - MARKET FACTORS
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Managed Care and Healthcare Economics
COMPANY PROFILES
THE INJECTION DEVICE ECOSYSTEM
DEVICE MANUFACTURERS
CAPABILITIES AND GEOGRAPHIC PRESENCE
SUPPLY CHAIN DYNAMICS
ALLIANCES AND COLLABORATIONS
DESIGN AND TECHNOLOGY
DEVICE DESIGN
SPECIALTY SERVICES
CMOS AND CSOS
FILL AND FINISH OPERATIONS
SPECIALTY SERVICES
INJECTION DEVICE SELECTION CRITERIA
STABILITY AND MATERIAL SELECTION ISSUES
SINGLE VS MULTI-DOSE DEVICES
LYOPHILIZED DRUGS/RECONSTITUTION
SYRINGE SAFETY/SHARPS PROTECTION
NEEDLE CONFIGURATION STRATEGIES
DISPOSABLE DRUG CARTRIDGES
HUMAN ENGINEERING/ERGONOMICS
BRANDING/PRIVATE LABELING
INJECTABLE DRUG DELIVERY – DEVICE SEGMENTS
AUTOINJECTORS
Autoinjector-specific Selection Factors
PART COUNTS AND DEVICE COST
SAFETY FEATURES
NEEDLE SHIELDING
NEEDLE INSERTION DEPTH
Failsafe Activation
Dose Inspection/Injection Confirmation
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Drugs and Therapeutic Segments
NEEDLE-FREE INJECTORS
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Energy Source/Injection Site Selection
PEN INJECTORS
Pen Injector Device Categories
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Branded Drug/Pen Injector Product by Therapeutic Segment
PREFILLED SYRINGES
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Prefillable Glass Syringe Manufacturers and Branded Devices
Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
Plastic Prefilled Syringes
Branded Prefillable Plastic Syringes
Drugs and Therapeutic Segments
Prefillable Safety Syringes
Prefilled Syringe-specific Selection Factors
PFS+C109 Manufacturing Factors
FILL-AND-FINISH OPERATIONS
SAFETY SYRINGES
Safety Syringe Device Categories
Prefillable Integrated Safety Syringes
Non-Prefillable Integrated Safety Syringes
Retractable Needle
Manually Retractable
Automatic Retractable
Sliding Sheath
DRUG INJECTION DEVICE MARKET SEGMENT ANALYSIS & FORECASTS
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Emergency Medicine
Hematopoietics
Hormone Replacement
Metabolic Diseases
Neurology
Reproductive Health
Vaccines
INJECTABLE DRUG THERAPEUTICS - MARKET FACTORS
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Managed Care and Healthcare Economics
COMPANY PROFILES
DEVICE MANUFACTURERS
CAPABILITIES AND GEOGRAPHIC PRESENCE
SUPPLY CHAIN DYNAMICS
ALLIANCES AND COLLABORATIONS
DESIGN AND TECHNOLOGY
DEVICE DESIGN
SPECIALTY SERVICES
CMOS AND CSOS
FILL AND FINISH OPERATIONS
SPECIALTY SERVICES
INJECTION DEVICE SELECTION CRITERIA
STABILITY AND MATERIAL SELECTION ISSUES
SINGLE VS MULTI-DOSE DEVICES
LYOPHILIZED DRUGS/RECONSTITUTION
SYRINGE SAFETY/SHARPS PROTECTION
NEEDLE CONFIGURATION STRATEGIES
DISPOSABLE DRUG CARTRIDGES
HUMAN ENGINEERING/ERGONOMICS
BRANDING/PRIVATE LABELING
INJECTABLE DRUG DELIVERY – DEVICE SEGMENTS
AUTOINJECTORS
Autoinjector-specific Selection Factors
PART COUNTS AND DEVICE COST
SAFETY FEATURES
NEEDLE SHIELDING
NEEDLE INSERTION DEPTH
Failsafe Activation
Dose Inspection/Injection Confirmation
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Drugs and Therapeutic Segments
NEEDLE-FREE INJECTORS
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Energy Source/Injection Site Selection
PEN INJECTORS
Pen Injector Device Categories
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Branded Drug/Pen Injector Product by Therapeutic Segment
PREFILLED SYRINGES
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Prefillable Glass Syringe Manufacturers and Branded Devices
Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
Plastic Prefilled Syringes
Branded Prefillable Plastic Syringes
Drugs and Therapeutic Segments
Prefillable Safety Syringes
Prefilled Syringe-specific Selection Factors
PFS Manufacturing Factors
FILL-AND-FINISH OPERATIONS
SAFETY SYRINGES
Safety Syringe Device Categories
Prefillable Integrated Safety Syringes
Non-Prefillable Integrated Safety Syringes
Retractable Needle
Manually Retractable
Automatic Retractable
Sliding Sheath
DRUG INJECTION DEVICE MARKET SEGMENT ANALYSIS & FORECASTS
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Emergency Medicine
Hematopoietics
Hormone Replacement
Metabolic Diseases
Neurology
Reproductive Health
Vaccines
INJECTABLE DRUG THERAPEUTICS - MARKET FACTORS
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Managed Care and Healthcare Economics
COMPANY PROFILES
THE INJECTION DEVICE ECOSYSTEM
DEVICE MANUFACTURERS
CAPABILITIES AND GEOGRAPHIC PRESENCE
SUPPLY CHAIN DYNAMICS
ALLIANCES AND COLLABORATIONS
DESIGN AND TECHNOLOGY
DEVICE DESIGN
SPECIALTY SERVICES
CMOS AND CSOS
FILL AND FINISH OPERATIONS
SPECIALTY SERVICES
INJECTION DEVICE SELECTION CRITERIA
STABILITY AND MATERIAL SELECTION ISSUES
SINGLE VS MULTI-DOSE DEVICES
LYOPHILIZED DRUGS/RECONSTITUTION
SYRINGE SAFETY/SHARPS PROTECTION
NEEDLE CONFIGURATION STRATEGIES
DISPOSABLE DRUG CARTRIDGES
HUMAN ENGINEERING/ERGONOMICS
BRANDING/PRIVATE LABELING
INJECTABLE DRUG DELIVERY – DEVICE SEGMENTS
AUTOINJECTORS
Autoinjector-specific Selection Factors
PART COUNTS AND DEVICE COST
SAFETY FEATURES
NEEDLE SHIELDING
NEEDLE INSERTION DEPTH
Failsafe Activation
Dose Inspection/Injection Confirmation
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Drugs and Therapeutic Segments
NEEDLE-FREE INJECTORS
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Energy Source/Injection Site Selection
PEN INJECTORS
Pen Injector Device Categories
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Branded Drug/Pen Injector Product by Therapeutic Segment
PREFILLED SYRINGES
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Prefillable Glass Syringe Manufacturers and Branded Devices
Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
Plastic Prefilled Syringes
Branded Prefillable Plastic Syringes
Drugs and Therapeutic Segments
Prefillable Safety Syringes
Prefilled Syringe-specific Selection Factors
PFS+C109 Manufacturing Factors
FILL-AND-FINISH OPERATIONS
SAFETY SYRINGES
Safety Syringe Device Categories
Prefillable Integrated Safety Syringes
Non-Prefillable Integrated Safety Syringes
Retractable Needle
Manually Retractable
Automatic Retractable
Sliding Sheath
DRUG INJECTION DEVICE MARKET SEGMENT ANALYSIS & FORECASTS
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Emergency Medicine
Hematopoietics
Hormone Replacement
Metabolic Diseases
Neurology
Reproductive Health
Vaccines
INJECTABLE DRUG THERAPEUTICS - MARKET FACTORS
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Managed Care and Healthcare Economics
COMPANY PROFILES
